Table 5 30-day follow-up of patients
From: Morbidity and mortality of nonagenarians undergoing CoreValve implantation
30-day outcome | |
|---|---|
Mortality, n (%) | |
All cause n (%) | 3 (27.3) |
Cardiovascular, n(%) | 1 (9.1) |
Stroke, n (%) | |
Major | 1 (9.1) |
Minor | 2 (18.2) |
TIA, n (%) | 3 (27.2) |
Myocardial infarction, n (%) | |
Periprocedural (<72h) | 1 (9.1) |
Spontaneous (>72h) | 1 (9.1) |
New need for hemodialysis | 2 (18.2) |
Bleeding, n (%) | |
Life-threatening or disabling | 2 (18.2) |
Major | 0 (0) |
Minor | 7 (63.6) |
Vascular complication | |
Major | 1 (9.1) |
Minor | 3 (27.3) |
Pulmonary embolism | 2 (18.2) |
Combined safety endpoints | 10 (90.9) |
Need for Pacing, n (%) | 5 (45.5) |
New left bundle branch block | 7 (63.7) |
New second or third-degree AV block | 5 (45.5) |
NYHA functional class | 1.36 ± 0.5 |
Cardiac decompensation, n (%) | 2 (18.2) |
Syncope, n (%) | 0 (0) |
Need for hospitalization due to cardiac causes, n (%) | 3 (27.2) |
Need for Re-do (TAVI or Surgery) | 0 (0) |
Echocardiographic parameters | |
Left ventricular ejection fraction (%) | 45.6 ± 6.9 |
Left ventriclura end-diastolic diameter (mm) | 50.1 ± 7.1 |
Aortic valve area (cm2) | 1.8 ± 0.2 |
Aortic peak pressure gradient (mmHg) | 16.6 ± 6.7 |
Aortic mean pressure gradient (mmHg) | 8.3 ± 3.9 |
Interventricular septal dimension (mm) | 13.5 ± 1.6 |
Aortic regurgitation, n (%) | |
Grade I | 9 (81.9) |
Grade II | 2 (18.2) |
Grade III | 0 (0) |
Pulmonal artery systolic pressure | 45.7 ± 14.6 |
Mitral insufficiency (%) | |
Grade I | 8 (72.8) |
Grade II | 2 (18.2) |
Grade III | 0 (0) |